Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) EPS (Weighted Average and Diluted) (2020 - 2025)

Outset Medical (OM) has disclosed EPS (Weighted Average and Diluted) for 6 consecutive years, with -$1.0 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 86.21% to -$1.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.37, a 85.47% increase, with the full-year FY2025 number at -$5.37, up 85.47% from a year prior.
  • EPS (Weighted Average and Diluted) was -$1.0 for Q4 2025 at Outset Medical, down from -$0.8 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.09 in Q2 2025 to a low of -$49.55 in Q4 2023.
  • A 5-year average of -$5.04 and a median of -$0.9 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): crashed 5798.81% in 2023, then surged 100.9% in 2025.
  • Outset Medical's EPS (Weighted Average and Diluted) stood at -$0.88 in 2021, then grew by 4.55% to -$0.84 in 2022, then plummeted by 5798.81% to -$49.55 in 2023, then surged by 85.37% to -$7.25 in 2024, then skyrocketed by 86.21% to -$1.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's EPS (Weighted Average and Diluted) are -$1.0 (Q4 2025), -$0.8 (Q3 2025), and $0.09 (Q2 2025).